These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 12579530)
1. Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms. Silva J; Silva JM; Domínguez G; García JM; Cantos B; Rodríguez R; Larrondo FJ; Provencio M; España P; Bonilla F J Pathol; 2003 Mar; 199(3):289-97. PubMed ID: 12579530 [TBL] [Abstract][Full Text] [Related]
2. Analysis of genetic and epigenetic processes that influence p14ARF expression in breast cancer. Silva J; Domínguez G; Silva JM; García JM; Gallego I; Corbacho C; Provencio M; España P; Bonilla F Oncogene; 2001 Jul; 20(33):4586-90. PubMed ID: 11494155 [TBL] [Abstract][Full Text] [Related]
3. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression. Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942 [TBL] [Abstract][Full Text] [Related]
4. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835 [TBL] [Abstract][Full Text] [Related]
5. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck. Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502 [TBL] [Abstract][Full Text] [Related]
6. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland. Weber A; Langhanki L; Schütz A; Wittekind C; Bootz F; Tannapfel A J Pathol; 2002 Nov; 198(3):326-34. PubMed ID: 12375265 [TBL] [Abstract][Full Text] [Related]
7. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma. Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936 [TBL] [Abstract][Full Text] [Related]
8. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer. Hsu HS; Wang YC; Tseng RC; Chang JW; Chen JT; Shih CM; Chen CY; Wang YC Clin Cancer Res; 2004 Jul; 10(14):4734-41. PubMed ID: 15269146 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. Xing EP; Nie Y; Song Y; Yang GY; Cai YC; Wang LD; Yang CS Clin Cancer Res; 1999 Oct; 5(10):2704-13. PubMed ID: 10537333 [TBL] [Abstract][Full Text] [Related]
10. [Relationship between alterations of p16INK4a and p14ARF genes of CDKN2A locus and gastric carcinogenesis]. Tang SH; Yang DH; Luo HS; Yu JP; Shu JC Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):517-21. PubMed ID: 15231134 [TBL] [Abstract][Full Text] [Related]
11. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma. Tannapfel A; Sommerer F; Benicke M; Weinans L; Katalinic A; Geissler F; Uhlmann D; Hauss J; Wittekind C J Pathol; 2002 Aug; 197(5):624-31. PubMed ID: 12210082 [TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma. Ito S; Ohga T; Saeki H; Watanabe M; Kakeji Y; Morita M; Yamada T; Maehara Y Anticancer Res; 2007; 27(5A):3345-53. PubMed ID: 17970080 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis. Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762 [TBL] [Abstract][Full Text] [Related]
14. Alterations of p14ARF and p16INK4a genes in salivary gland carcinomas. Nishimine M; Nakamura M; Kishi M; Okamoto M; Shimada K; Ishida E; Kirita T; Konishi N Oncol Rep; 2003; 10(3):555-60. PubMed ID: 12684623 [TBL] [Abstract][Full Text] [Related]
15. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer. Kawamoto K; Enokida H; Gotanda T; Kubo H; Nishiyama K; Kawahara M; Nakagawa M Biochem Biophys Res Commun; 2006 Jan; 339(3):790-6. PubMed ID: 16316628 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of p16INK4a and p14ARF gene hypermethylation in human colon cancer. Lee M; Sup Han W; Kyoung Kim O; Hee Sung S; Sun Cho M; Lee SN; Koo H Pathol Res Pract; 2006; 202(6):415-24. PubMed ID: 16675157 [TBL] [Abstract][Full Text] [Related]
17. Promoter methylations of p16INK4a and p14ARF genes in early and advanced gastric cancer. Correlations of the modes of their occurrence with histologic type. Tsujimoto H; Hagiwara A; Sugihara H; Hattori T; Yamagishi H Pathol Res Pract; 2002; 198(12):785-94. PubMed ID: 12608655 [TBL] [Abstract][Full Text] [Related]
18. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Esteller M; Tortola S; Toyota M; Capella G; Peinado MA; Baylin SB; Herman JG Cancer Res; 2000 Jan; 60(1):129-33. PubMed ID: 10646864 [TBL] [Abstract][Full Text] [Related]
19. Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer. Brenner AJ; Paladugu A; Wang H; Olopade OI; Dreyling MH; Aldaz CM Clin Cancer Res; 1996 Dec; 2(12):1993-8. PubMed ID: 9816158 [TBL] [Abstract][Full Text] [Related]
20. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines. Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]